Table 2. Prevalence of metabolic syndrome according to the IDF, NCEP ATP III and modified WHO definitions.
| Variable | Definition of metabolic syndromea, n (%) | |||||||
|---|---|---|---|---|---|---|---|---|
| IDF | NCEP ATP | Modified WHO | ||||||
| Case | Control | Case | Control | Case | Control | |||
| Total | 99 (70.7) | 110 (39.3) | 97 (69.3) | 135 (48.2) | 85 (60.7) | 117 (41.8) | ||
| Gender | ||||||||
| Male | 46 (46.2) | 48 (43.6) | 50 (51.5) | 65 (48.1) | 44 (51.8) | 65 (55.6) | ||
| Female | 53 (53.8) | 62 (56.4) | 47 (48.5) | 70 (51.9) | 41 (48.2) | 52 (44.4) | ||
| Ethnic | ||||||||
| Malay | 40 (40.4) | 45 (40.9) | 35 (36.1) | 49 (36.3) | 31 (36.5) | 40 (34.2) | ||
| Chinese | 35 (35.4) | 32 (29.1) | 36 (51.2) | 48 (35.6) | 29 (34.1) | 42 (35.9) | ||
| Indian | 24 (24.2) | 33 (30.0) | 7 (16.3) | 38 (28.1) | 25 (29.4) | 35 (29.9) | ||
| Age categories (years) | ||||||||
| 30–39 | 2 (2.5) | 4 (3.6) | 5 (5.2) | 7 (5.2) | 4 (4.7) | 4 (3.4) | ||
| 40–49 | 10 (10.1) | 16 (14.5) | 10 (10.3) | 15 (11.1) | 10 (11.8) | 10 (8.5) | ||
| 50–59 | 27 (27.3) | 27 (24.5) | 25 (25.8) | 30 (22.2) | 20 (23.5) | 22 (18.8) | ||
| 60–69 | 33 (33.3) | 32 (29.1) | 30 (30.9) | 40 (29.6) | 25 (29.4) | 41 (35.0) | ||
| >70 | 27 (26.8) | 31 (28.2) | 27 (27.8) | 43 (31.9) | 26 (30.6) | 40 (34.2) | ||
a, MetS were defined based on World Health Organization (WHO) (Laaksonen et al., 2002), National Cholesterol Education Program Adults Treatment Panel III (NCEP ATP III) (Grundy et al., 2005) and International Diabetes Federation (IDF) criteria (Alberti et al., 2006) criteria.